Prevalence of multiple drug-resistant helicobacter pylori strains among patients with different gastric disorders in Iran
MetadataShow full item record
Emergence of multidrug-resistant (MDR) strains of Helicobacter pylori is a global health concern. This study was aimed to determine the frequency of MDR H. pylori strains in Iran. H. pylori isolates were obtained from cultured gastric biopsy samples on selective culture media after their characterization by PCR and conventional biochemical methods. The minimal inhibitory concentrations of rifampicin, ciprofloxacin, levofloxacin, ampicillin, clarithromycin, erythromycin, metronidazole, and tetracycline were determined for 111 strains that were isolated from 197 dyspeptic patients by the agar dilution method. The primary resistance rates were 61.3% (68/111) for metronidazole, 15.3% (17/111) for ampicillin, and 14.4% (16/111) for rifampicin. Resistance rates for other antimicrobials were as follows: macrolides (erythromycin or clarithromycin) 32.4% (36/111) and quinolones (levofloxacin or ciprofloxacin) 30.6% (34/111). Among the resistant strains, the rates of double and multiple drug resistance phenotypes were 22.6% (19/84) and 34.5% (29/84), respectively. The quadruple drug resistance phenotype encompasses 37.9% of the MDR strains, of which 90% of them was resistant to metronidazole. In conclusion, these results showed a high frequency of MDR phenotypes among the studied H. pylori strains in Iran. The eradication of the H. pylori strains presenting high resistance rates to macrolides, fluoroquinolones, or metronidazole could be achieved by approved tetracycline- or amoxicillin-containing regimens as alternative regimens to standard triple therapy. آ© Copyright 2015, Mary Ann Liebert, Inc. 2015.
Showing items related by title, author, creator and subject.
Non-Helicobacter pylori, non-nsaids peptic ulcers: A descriptive study on patients referred to taleghani hospital with upper gastrointestinal bleeding Rajabalinia, H; Ghobakhlou, M; Nikpour, S; Dabiri, R; Bahriny, R; Sherafat, SJ; Moghaddam, PK; Alizadeh, AM (2012)Aim: The purpose of the present study was to evaluate the number and proportion of various causes of upper gastrointestinal bleeding and actual numbers of non-NSAID, non-Helicobacter pylori (H.pylori) peptic ulcers seen ...
Triple therapy using two dosages of metronidazole along with amoxicillin and omeprazole to eradicate Helicobacter pylori infection: A randomized, open study  Fattahi, E; Motamedi, R; Nayebi, ARM; Rezazadeh, H; Shakir, A (2004)[No abstract available]
The effect of Helicobacter pylori infection on oxidative and nitrosative stress of gastric mucosa in sufferers from peptic ulcers in Tabriz City Seyedizadeh, S; Nouri, M; Jafari, B (2016)Helicobacter pylori infection causes different clinical and pathological symptoms in human, such as chronic gastritis, peptic ulcer and gastric neoplasia. In this study, nitric oxide levels and activity of superoxide ...